- E-mailBjarne.Hansen@uib.no
- Phone+47 55 58 88 87+47 920 90 765
- Visitor AddressMøllendalsbakken 9, 3. etg.
- Postal AddressPostboks 78075020 Bergen
- 2021. Treatment Adherence as Predictor of Outcome in Concentrated Exposure Treatment for Obsessive-Compulsive Disorder. Frontiers in Psychiatry. 8 pages.
- 2021. Does Concentrated Exposure Treatment for Obsessive-Compulsive Disorder Improve Insomnia Symptoms? Results From a Randomized Controlled Trial. Frontiers in Psychiatry. 7 pages.
- 2021. Disentangling Within- and Between-Person Effects During Response Inhibition in Obsessive-Compulsive Disorder. Frontiers in Psychiatry.
- 2021. Diffusion Tensor Imaging Before and 3 Months After Concentrated Exposure Response Prevention in Obsessive-Compulsive Disorder. Frontiers in Psychiatry. 1-11.
- 2020. The Bergen 4-Day Treatment (B4DT) for Obsessive-Compulsive Disorder: Outcomes for Patients Treated After Initial Waiting List or Self-Help Intervention. Frontiers in Psychology. 1-9.
- 2020. Stable inhibition-related inferior frontal hypoactivation and fronto-limbic hyperconnectivity in obsessive–compulsive disorder after concentrated exposure therapy. NeuroImage: Clinical. 1-8.
- 2020. Effects of Bergen 4-day treatment on resting-state graph features in obsessive-compulsive disorder. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging. 1-10.
- 2020. Effect of D-Cycloserine on the Effect of Concentrated Exposure and Response Prevention in Difficult-to-Treat Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Network Open. 1-13.
- 2019. Implementation of the Bergen 4-day treatment for obsessive compulsive disorder in Iceland. Clinical Neuropsychiatry. 33-38.
- 2019. Dispositional resilience in treatment‐seeking patients with obsessive‐compulsive disorder and its association with treatment outcome. Scandinavian Journal of Psychology. 243-251.
More information in national current research information system (CRIStin)